“And I must say that 99% of my patients had previously untreated undiagnosed, mast cell activation syndrome.” — Dr. Tina Peers
Recently, IMA Senior Fellow Dr. Tina Peers contributed to a peer-reviewed study published in Advances in Virology along with several IMA co-authors including Co-Founder Dr. Paul Marik and Director of Research Matthew Halma. The study explored individual susceptibility to injuries caused by excess spike protein resulting from COVID-19 infection or vaccination.
In the above video, Dr. Peers gives us another important vantage to view the issue of spike-related injury. She emphasized the importance of individual factors such as genetics, nutrition, hormones, and pre-existing health conditions in how people respond to COVID infections and vaccines. In her clinical practice, which specializes in Long COVID and vaccine injuries, she applies orthomolecular medicine principles, underscoring that reactions vary significantly between individuals.
She highlights Mast Cell Activation Syndrome (MCAS), a condition affecting approximately 17-20% of the population, as particularly relevant. In her experience, nearly all of her Long COVID patients had undiagnosed MCAS prior to their illness. Symptoms of MCAS include chronic headaches, skin conditions, fibromyalgia, IBS, chronic fatigue, and POTS, caused by systemic inflammation from overly reactive mast cells. Dr. Peers advocates recognizing and addressing MCAS to better understand and manage both Long COVID and vaccine-related injuries.
For more information on the study Dr. Peers contributed to, check out these links below:
